Search
60 results
RUBIN GLASS has established itself as a preferred and reliable European partner*
Nikolay Mochev, CEO of Rubin Trading, tells Capital Weekly
The Week: Has the "Peevski spell" been broken, Business climate turns sour, Sofia bans dirty cars
K Insights Newsletter 01/11
The week: The Romanian way
The boom on the other side of the Danube, Where did 4 billion leva go, the biggest Renter in Sofia
The week: Who’s running the country?
Who is really in charge? Elections lurk on every corner and a pharmaceutical boom
Digitalk 2024: Artificial intelligence theory gives way to practice
The highlights and participants at this year's Economedia tech innovation conference
Industrial cooldown, slower business growth and less VAT collected: 2023 at a glance
Global events hit the financial performance of public companies, shrink factory production and effectively cut down state revenue
The biggest pharmaceutical companies: a duo joins the billion-dollar club
Two drug distributors - Sopharma Trading and Phoenix Pharma - crossed the BGN 1 billion mark for the first time in 2022
Biggest companies in Bulgaria: state-owned energy giants are forever
The revenue of the 100 largest companies in Bulgaria has increased more than 5 times in two decades
Biodiesel maker Astra Bioplant tops fuel sector’s ranking
Long-time leader Lukoil Neftochim Burgas drops to fourth position
Biggest pharma companies’ revenue grows 10% in 2021
Leaders Sopharma Trading and Phoenix approach a turnover of billion levs each
The "City Lovers" of Bulgaria
Three stories of active citizens, who have a plan how to make life better for their communities - sponsored by Capital and the British Embassy
Why do Bulgarians refuse to get the Covid vaccine?
Poor communication and broken trust in institutions left much of the public prone to disinformation and unjustified fears about the effects of jabs
The real Bugarian interests in N.Macedonia: in between diplomacy and business
Outstanding issues between Bulgaria and its southwestern neighbor are important, but it is critical to provide infrastructure and a stable business environment for companies
A call to action: a National Plan for Cardiovascular Health is urgently needed
The experts have reached a consensus; the ball is now in the institutions’ court